[
  {
    "title": "安旭生物(688075.SH)：聘任康敏为公司财务总监",
    "href": "http://stock.jrj.com.cn/2022/12/26171837238428.shtml",
    "datetime": "2022-12-26 17:18:41",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：“新型冠状病毒抗原检测试剂(笔型)”获得日本PMDA认证",
    "href": "http://stock.jrj.com.cn/2022/11/30164937178387.shtml",
    "datetime": "2022-11-30 16:49:40",
    "code": "688075"
  },
  {
    "title": "A股异动 | 安旭生物涨5% 新冠病毒抗原家用自测检测试剂获FDA紧急使用授权",
    "href": "http://stock.jrj.com.cn/2022/11/23094237159719.shtml",
    "datetime": "2022-11-23 09:42:42",
    "code": "688075"
  },
  {
    "title": "安旭生物：新冠病毒抗原家用自测检测试剂获FDA紧急使用授权",
    "href": "http://stock.jrj.com.cn/2022/11/22170237157788.shtml",
    "datetime": "2022-11-22 17:02:38",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：“新型冠状病毒抗原家用自测检测试剂\"获得美国FDA认证",
    "href": "http://stock.jrj.com.cn/2022/11/22165437157772.shtml",
    "datetime": "2022-11-22 16:54:12",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：拟使用不超3亿元部分暂时闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/09/26154037021535.shtml",
    "datetime": "2022-09-26 15:40:00",
    "code": "688075"
  },
  {
    "title": "安旭生物披露2022年半年报 实现营收59.30亿元",
    "href": "http://stock.jrj.com.cn/2022/08/30111536951733.shtml",
    "datetime": "2022-08-30 11:15:45",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：上半年实现净利润28.78亿元 同比增长1323.67%",
    "href": "http://stock.jrj.com.cn/2022/08/29204836949007.shtml",
    "datetime": "2022-08-29 20:48:14",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：2021年度权益分派10转4.8派38.8元 股权登记日为7月4日",
    "href": "http://stock.jrj.com.cn/2022/06/28204236765819.shtml",
    "datetime": "2022-06-28 20:42:14",
    "code": "688075"
  },
  {
    "title": "A股异动 | 安旭生物(688075.SH)涨6% 5款猴痘检测产品获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/06/07104836708256.shtml",
    "datetime": "2022-06-07 10:48:26",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：5款猴痘检测产品获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/06/06192036706722.shtml",
    "datetime": "2022-06-06 19:20:49",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：新型冠状病毒抗原唾液检测试剂盒(笔型)取得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/05/30193336690677.shtml",
    "datetime": "2022-05-30 19:33:52",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：取得3款检测试剂的海外医疗器械注册证书",
    "href": "http://stock.jrj.com.cn/2022/05/12154636642843.shtml",
    "datetime": "2022-05-12 15:46:43",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075)首次公开发行网下配售限售股于2022年5月18日上市流通",
    "href": "http://stock.jrj.com.cn/2022/05/10085436615948.shtml",
    "datetime": "2022-05-10 08:54:12",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：65.7624万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/05/09175236608309.shtml",
    "datetime": "2022-05-09 17:52:47",
    "code": "688075"
  },
  {
    "title": "快讯：安旭生物急速拉升5.65% 主力资金净流入1275.25万元(dev)",
    "href": "http://stock.jrj.com.cn/2022/05/09095136603037.shtml",
    "datetime": "2022-05-09 09:51:00",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)2021年度权益分派预案：拟10转4.8派38.8元",
    "href": "http://stock.jrj.com.cn/2022/05/06175536581789.shtml",
    "datetime": "2022-05-06 17:55:49",
    "code": "688075"
  },
  {
    "title": "体外诊断市场规模快速扩张 安旭生物业绩暴增31倍靠的啥",
    "href": "http://stock.jrj.com.cn/2022/05/06083436577194.shtml",
    "datetime": "2022-05-06 08:34:00",
    "code": "688075"
  },
  {
    "title": "安旭生物2022年第一季度净利26.82亿同比增长3147.87% 新冠产品市场销售规模增大",
    "href": "http://stock.jrj.com.cn/2022/05/03193236546599.shtml",
    "datetime": "2022-05-03 19:32:58",
    "code": "688075"
  },
  {
    "title": "安旭生物2021年净利7.39亿同比增长13.8% 董事长凌世生薪酬172.15万",
    "href": "http://stock.jrj.com.cn/2022/05/02173236533023.shtml",
    "datetime": "2022-05-02 17:32:40",
    "code": "688075"
  },
  {
    "title": "安旭生物披露2022年一季报 实现营收54.75亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28090836490324.shtml",
    "datetime": "2022-04-28 09:08:49",
    "code": "688075"
  },
  {
    "title": "安旭生物披露2021年年报 实现营收15.89亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28090836490326.shtml",
    "datetime": "2022-04-28 09:08:22",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：2021年净利增13.80%至7.39亿元 拟10派38.8元",
    "href": "http://stock.jrj.com.cn/2022/04/27222636487000.shtml",
    "datetime": "2022-04-27 22:26:44",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：一季度净利润增3147.87%至26.82亿元",
    "href": "http://stock.jrj.com.cn/2022/04/27222336487013.shtml",
    "datetime": "2022-04-27 22:23:59",
    "code": "688075"
  },
  {
    "title": "安旭生物2021年净利7.39亿同比增长13.82% 销售规模持续扩大",
    "href": "http://stock.jrj.com.cn/2022/02/25183034465445.shtml",
    "datetime": "2022-02-25 18:30:38",
    "code": "688075"
  },
  {
    "title": "两机构席位买入安旭生物",
    "href": "http://stock.jrj.com.cn/hotstock/2022/02/09082834311840.shtml",
    "datetime": "2022-02-09 08:28:08",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：公司相关新冠检测产品获得欧盟CE认证非独家专属风险",
    "href": "http://stock.jrj.com.cn/2022/01/14180234158468.shtml",
    "datetime": "2022-01-14 18:02:51",
    "code": "688075"
  },
  {
    "title": "新冠检测板块进一步拉升：安旭生物、美康生物、东方生物午后封板",
    "href": "http://stock.jrj.com.cn/2022/01/14135734157387.shtml",
    "datetime": "2022-01-14 13:57:32",
    "code": "688075"
  },
  {
    "title": "A股异动 | 安旭生物(688075.SH)续升超13% 再创新高",
    "href": "http://stock.jrj.com.cn/2022/01/14103434156852.shtml",
    "datetime": "2022-01-14 10:34:27",
    "code": "688075"
  },
  {
    "title": "安旭生物：拟使用超募资金投建体外诊断试剂以及诊断仪器研发生产项目",
    "href": "http://stock.jrj.com.cn/2022/01/12185534150908.shtml",
    "datetime": "2022-01-12 18:55:00",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：拟投建体外诊断试剂以及诊断仪器研发生产项目",
    "href": "http://stock.jrj.com.cn/2022/01/12181634150763.shtml",
    "datetime": "2022-01-12 18:16:46",
    "code": "688075"
  },
  {
    "title": "上海证券研究所预测公司2022年-2023年业绩？安旭生物这样澄清",
    "href": "http://stock.jrj.com.cn/2022/01/12112534149167.shtml",
    "datetime": "2022-01-12 11:25:39",
    "code": "688075"
  },
  {
    "title": "安旭生物澄清：上海证券对公司业绩预测不代表公司 未向其提供过尚未披露业绩数据",
    "href": "http://stock.jrj.com.cn/2022/01/12093934148714.shtml",
    "datetime": "2022-01-12 09:39:10",
    "code": "688075"
  },
  {
    "title": "【晚间公告抢先看】四连板安旭生物称招临时工和实习生属于公司经营正常需求，“年报预增”利好来袭……",
    "href": "http://stock.jrj.com.cn/2022/01/11211034147675.shtml",
    "datetime": "2022-01-11 21:10:45",
    "code": "688075"
  },
  {
    "title": "安旭生物：招临时工和实习生属于公司经营正常需求",
    "href": "http://stock.jrj.com.cn/2022/01/11203434147506.shtml",
    "datetime": "2022-01-11 20:34:07",
    "code": "688075"
  },
  {
    "title": "四连板安旭生物：招临时工和实习生属于公司经营正常需求",
    "href": "http://stock.jrj.com.cn/2022/01/11184034147073.shtml",
    "datetime": "2022-01-11 18:40:41",
    "code": "688075"
  },
  {
    "title": "国内疫情多处散点发生推动新冠检测股拉升，安旭生物、九安医疗等多股涨停",
    "href": "http://stock.jrj.com.cn/2022/01/11134334145684.shtml",
    "datetime": "2022-01-11 13:43:34",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：新冠病毒抗原鼻腔检测试剂(自测)取得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/12/26161834062026.shtml",
    "datetime": "2021-12-26 16:18:40",
    "code": "688075"
  },
  {
    "title": "安旭生物：新型冠状病毒抗原快速检测试剂盒获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/12/26155034061975.shtml",
    "datetime": "2021-12-26 15:50:42",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：拟使用2.51亿元募集资金向艾旭生物增资以实施募投项目",
    "href": "http://stock.jrj.com.cn/2021/12/07191733981175.shtml",
    "datetime": "2021-12-07 19:17:19",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：拟使用不超8亿元超募资金及部分闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/12/07191533981164.shtml",
    "datetime": "2021-12-07 19:15:35",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：新型冠状病毒(2019-nCoV)抗原自测试剂的欧盟CE认证有效期延长",
    "href": "http://stock.jrj.com.cn/2021/12/03154333960085.shtml",
    "datetime": "2021-12-03 15:43:37",
    "code": "688075"
  },
  {
    "title": "A股异动 | 安旭生物涨8% 公司新型冠状病毒抗原自测试剂获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/11/23104133908323.shtml",
    "datetime": "2021-11-23 10:41:18",
    "code": "688075"
  },
  {
    "title": "安旭生物：公司相关检测产品获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/11/21155433892405.shtml",
    "datetime": "2021-11-21 15:54:33",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)新型冠状病毒抗原自测试剂取得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/11/21154233892295.shtml",
    "datetime": "2021-11-21 15:42:17",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：将于11月18日在科创板上市",
    "href": "http://stock.jrj.com.cn/2021/11/16204233861835.shtml",
    "datetime": "2021-11-16 20:42:12",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)IPO认购结果：网上网下共弃购19.59万股",
    "href": "http://stock.jrj.com.cn/2021/11/11212633837898.shtml",
    "datetime": "2021-11-11 21:26:46",
    "code": "688075"
  },
  {
    "title": "安旭生物披露网上发行中签结果 末“4”位数为4118、9118",
    "href": "http://stock.jrj.com.cn/2021/11/10111933831144.shtml",
    "datetime": "2021-11-10 11:19:46",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：网上摇号中签号共11685个 民生证券投资获配61.3336万股",
    "href": "http://stock.jrj.com.cn/2021/11/09191033828617.shtml",
    "datetime": "2021-11-09 19:10:32",
    "code": "688075"
  },
  {
    "title": "【兑奖啦】科创板安旭生物、盛美上海、新点软件网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2021/11/09191033828616.shtml",
    "datetime": "2021-11-09 19:10:04",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：网上发行最终中签率为0.02969210%",
    "href": "http://stock.jrj.com.cn/2021/11/08191633824150.shtml",
    "datetime": "2021-11-08 19:16:20",
    "code": "688075"
  },
  {
    "title": "安旭生物(688075.SH)：IPO定价为78.28元/股 11月8日开启申购",
    "href": "http://stock.jrj.com.cn/2021/11/04192333813827.shtml",
    "datetime": "2021-11-04 19:23:15",
    "code": "688075"
  },
  {
    "title": "安旭生物冲刺科创板，IPO注册生效更新动态",
    "href": "http://stock.jrj.com.cn/2021/10/12100133677719.shtml",
    "datetime": "2021-10-12 10:01:23",
    "code": "688075"
  },
  {
    "title": "安旭生物涉嫌海外造假 IPO注册仍无结果",
    "href": "http://stock.jrj.com.cn/ipo/2021/04/07074732322616.shtml",
    "datetime": "2021-04-07 07:47:37",
    "code": "688075"
  },
  {
    "title": "IPO最后时刻 安旭生物被曝临床数据造假",
    "href": "http://stock.jrj.com.cn/ipo/2021/01/22073731742195.shtml",
    "datetime": "2021-01-22 07:37:15",
    "code": "688075"
  },
  {
    "title": "安旭生物：今年科创板过会第157家 民生证券过8单",
    "href": "http://stock.jrj.com.cn/2020/11/04105631213906.shtml",
    "datetime": "2020-11-04 10:56:00",
    "code": "688075"
  },
  {
    "title": "外销占比超九成 安旭生物回复科创板IPO落实函补充披露毛利率波动风险 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/10/27114231140918.shtml",
    "datetime": "2020-10-27 11:42:22",
    "code": "688075"
  },
  {
    "title": "艾隆科技、安旭生物11月3日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/10/23202531118768.shtml",
    "datetime": "2020-10-23 20:25:00",
    "code": "688075"
  },
  {
    "title": "安旭生物科创板IPO申请获受理",
    "href": "http://stock.jrj.com.cn/kcb/2020/06/04054829840515.shtml",
    "datetime": "2020-06-04 05:48:56",
    "code": "688075"
  }
]